Skip to main content

Praxis Precision Medicines, Inc.

PRAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001689548

No open-market purchases or sales by Praxis Precision Medicines, Inc. insiders were filed in the last 90 days; 309 institutions reported holding it in 13F filings for Q2 2026, worth $11.3B in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Praxis Precision Medicines, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of PRAX: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders103295−6
Shares45.4M20.6K43.1M−2.24M (−4.9%)
Value$463.4M$210.0K$105.5M−$357.7M (−77.2%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (21)

Institutions that held Praxis Precision Medicines, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to PRAX in Q2 2022
InstitutionSharesValue% of portfolio
Acadian Asset Management LLC829,117$2.03M0.01%
UBS Oconnor LLC215,776$529.0K0.01%
Occudo Quantitative Strategies LP212,830$521.0K0.04%
EcoR1 Capital, LLC210,100$515.0K0.02%
Schonfeld Strategic Advisors LLC172,978$423.0K0.00%
Los Angeles Capital Management LLC107,445$263.0K0.00%
ExodusPoint Capital Management, LP103,819$254.0K0.00%
Jane Street Group, LLC96,930$238.0K0.00%
D. E. Shaw & Co., Inc.96,923$237.0K0.00%
XTX Topco Ltd71,196$174.0K0.07%
Graham Capital Management, L.P.54,016$132.0K0.01%
SG Americas Securities, LLC49,223$121.0K0.00%
PEAK6 Investments LLC74,468$85.6K0.00%
E Fund Management Co., Ltd.26,064$64.0K0.01%
Simplex Trading, LLC24,788$60.0K0.00%
Squarepoint Ops LLC21,560$53.0K0.00%
Cornercap Investment Counsel Inc20,008$49.0K0.01%
AQR Capital Management LLC17,396$43.0K0.00%
Cutler Group LP1,700$4.00K0.00%
Captrust Financial Advisors1,345$3.00K0.00%
Quadrant Capital Group LLC408$1.00K0.00%

Sold out (27)

Institutions that held Praxis Precision Medicines, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (2)

Institutions that held Praxis Precision Medicines, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PRAX in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Susquehanna Fundamental Investments, LLC16,453$168.0K
Amalgamated Financial Corp.4,137$42.0K